ASCO26: Platinum-resistant ADC leader Elahere stumbles in platinum-sensitive disease - Pharmaceutical Technology

The MIROVA miss dampens prospects for Elahere's near-term label expansion into platinum-sensitive disease.

Raccontata dapharmaceutical-technology.com